1. Corrigendum to the article entitled “Circulating tumor cells (CTCs) from metastatic breast cancer patients linked to decreased immune function and response to treatment”[Exp. Mol. Pathol. 95/2 (2013) 174–179]

    Experimental and Molecular Pathology 96(1):132 (2014)

  2. Corrigendum to the article entitled “Circulating tumor cells (CTCs) from metastatic breast cancer patients linked to decreased immune function and response to treatment”[Exp. Mol. Pathol. 95/2 (2013) 174–179]

    Experimental and Molecular Pathology 96(1) (2014)

  3. DRβ1*1501, DQβ1*0602 donor allelic haplotype and humoral antibody episodes of acute renal allograft rejection.

    Experimental and Molecular Pathology 89(2):135 (2010) PMID 20599935

    The present investigation was designed to show the effect of molecular HLA class II DR and DQ allelic differences between donor and recipient on humoral antibody rejection identified by C4d peritubular capillary staining. The hypothesis is that expression of the DRβ1*1501, DQβ1*0602 allele in th...
  4. DRβ1*1501, DQβ1*0602 donor allelic haplotype and humoral antibody episodes of acute renal allograft rejection.

    Experimental and Molecular Pathology 89(2):135 (2010) PMID 20599935

    The present investigation was designed to show the effect of molecular HLA class II DR and DQ allelic differences between donor and recipient on humoral antibody rejection identified by C4d peritubular capillary staining. The hypothesis is that expression of the DRβ1*1501, DQβ1*0602 allele in th...
  5. DRβ1*1501, DQβ1*0602 donor allelic haplotype and humoral antibody episodes of acute renal allograft rejection

    Experimental and Molecular Pathology 89(2):135 (2010)

    The present investigation was designed to show the effect of molecular HLA class II DR and DQ allelic differences between donor and recipient on humoral antibody rejection identified by C4d peritubular capillary staining. The hypothesis is that expression of the DRβ1*1501, DQβ1*0602 allele ...
  6. DRβ1*1501, DQβ1*0602 donor allelic haplotype and humoral antibody episodes of acute renal allograft rejection

    Experimental and Molecular Pathology 89(2):135 (2010) PMID 20599935

    The present investigation was designed to show the effect of molecular HLA class II DR and DQ allelic differences between donor and recipient on humoral antibody rejection identified by C4d peritubular capillary staining. The hypothesis is that expression of the DRβ1*1501, DQβ1*0602 allele ...
  7. B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates.

    Nature Medicine 13(11):1295 (2007) PMID 17965721

    We found that an induction immunotherapy regimen consisting of rabbit anti-thymocyte globulin (Thymoglobulin) and the monoclonal antibody to CD20 rituximab (Rituxan) promoted long-term islet allograft survival in cynomolgus macaques maintained on rapamycin monotherapy. B lymphocyte reconstitutio...
  8. B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates.

    Nature Medicine 13(11):1295 (2007) PMID 17965721

    We found that an induction immunotherapy regimen consisting of rabbit anti-thymocyte globulin (Thymoglobulin) and the monoclonal antibody to CD20 rituximab (Rituxan) promoted long-term islet allograft survival in cynomolgus macaques maintained on rapamycin monotherapy. B lymphocyte reconstitutio...
  9. Corrigendum to the article entitled “Circulating tumor cells (CTCs) from metastatic breast cancer patients linked to decreased immune function and response to treatment”[Exp. Mol. Pathol. 95/2 (2013) 174–179]

    Experimental and Molecular Pathology in press